UBS AM
NBP

UBS AM’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

UBS AM’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-458,706
Closed -$1.84M – 2633
2022
Q3 		$1.84M Hold
458,706
– – ﹤0.01% 1644
2022
Q2 		$5.18M Buy
458,706
+254,876
+125% +$3.06M ﹤0.01% 1196
2022
Q1 		$3.31M Sell
203,830
-6,995
-3% -$179K ﹤0.01% 1533
2021
Q4 		$9.99M Buy
210,825
+91,021
+76% +$5.46M ﹤0.01% 1127
2021
Q3 		$8.68M Buy
119,804
+12,876
+12% +$931K ﹤0.01% 1143
2021
Q2 		$8.98M Buy
+106,928
New +$7.05M ﹤0.01% 1161

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UBS AM's NBP Position: Q4 2022 in Review

UBS AM sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 458,706 shares — an estimated $1.84M sold.

UBS AM first reported a position in NBP in Q2 2021 and held it in 6 quarters. The position peaked at $9.99M in Q4 2021. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

  • UBS AM reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • UBS AM sold 458,706 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $1.84M.
  • UBS AM first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 6 quarters.
  • UBS AM's NovaBridge Biosciences American Depositary Shares position peaked at $9.99M in Q4 2021.
  • 69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.